Charles Russell Speechlys advising Battery Ventures on the sale of SPT Labtech for £650 million.
Charles Russell Speechlys are advising the global, technology-focused investment firm Battery Ventures on the sale of SPT Labtech, a fast-growing laboratory automation player focused on tools for liquid handling and sample preparation and management for scientists, for £650 million to EQT Private Equity.
Founded in 1983, Battery Ventures has raised more than $9 billion to invest in software and services, enterprise infrastructure, online marketplaces, healthcare IT, and industrial technology around the world. The firm backs companies at all stages, ranging from seed and early to growth and buyout. Charles Russell Speechlys has worked with Battery for several years, and Jonathan Morley and the team are also advising on the sale of Forterro to Partners Group for €1 billion.
SPT Labtech, designs and builds world-leading lab automation solutions that provide agility, efficiency, and productivity to a range of applications.
Corporate partner Jonathan Morley led the Charles Russell Speechlys team, comprising Matthew Hobbs, Edward Robinson, Caminelle Apperly, Shane Thompson, Mark Bailey, Rayyan Mughal, Paul Stone and Sam Lawn.
